Previous close | 11.70 |
Open | 11.85 |
Bid | 11.25 |
Ask | 12.00 |
Strike | 35.00 |
Expiry date | 2026-01-16 |
Day's range | 11.85 - 11.85 |
Contract range | N/A |
Volume | |
Open interest | 500 |
The FDA has rescinded the marketing denial orders (MDOs) issued to JUUL Labs Inc., partially due to new case law and further information provided by JUUL. This rescission returns the applications to pending status and does not indicate whether they will be authorized or denied. The FDA continues its substantive review of the applications, adhering to its regulations, which limit the disclosure of pending application content. Related: E-Cigarette Maker Juul’s Financial Rescue Marred by Allegation
In this article, we will take a look at some of the best dividend stocks with over 7% yield according to hedge funds. Altria Group, Inc. (NYSE:MO) topped our list of the 10 Best Dividend Stocks with 7+% Yield and we have analyzed the stock in detail. High dividend yields are attractive. They show the […]
We recently published a list of the 9 best high-yield dividend growth stocks to buy according to hedge funds. Since Altria is part of the list, the stock needs a deeper look. But first, let’s take a look at why analysts believe investing in dividend stocks would make sense in 2024, especially when rates are […]